Arthur Allen, KFF Health News

Most recent articles by Arthur Allen, KFF Health News

Why millions are trying FDA-authorized alternatives to Big Pharma’s weight loss drugs
Why millions are trying FDA-authorized alternatives to Big Pharma’s weight loss drugs
Arthur Allen, KFF Health News
July 23, 2024
2:00 pm

The FDA allows and even encourages compounding pharmacies to produce and sell copycats when a drug is in short supply.

The chicken and egg problem of fighting another flu pandemic
The chicken and egg problem of fighting another flu pandemic
Arthur Allen, KFF Health News
May 31, 2024
10:30 am

The spread of an avian flu virus has decimated flocks of birds (and killed barn cats and other mammals).

Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
Arthur Allen, KFF Health News
May 7, 2024
2:30 pm

Cancer drug trials are structured to promote high doses, which then become routine patient care.

Overdosing on chemo: A common gene test could save hundreds of lives each year
Overdosing on chemo: A common gene test could save hundreds of lives each year
Arthur Allen, KFF Health News
March 26, 2024
2:05 pm

More than 275,000 cancer patients in the United States who are infused each year with fluorouracil, known as 5-FU.

Why COVID patients who could most benefit from Paxlovid still aren’t getting it
Why COVID patients who could most benefit from Paxlovid still aren’t getting it
Arthur Allen, KFF Health News
March 11, 2024
2:05 pm

The price is one reason Paxlovid is not reaching those who need it most. And patients who qualify for free doses often don’t realize it or know how to get them.

Patients see first savings from Biden’s drug price push, as pharma lines up its lawyers
Patients see first savings from Biden’s drug price push, as pharma lines up its lawyers
Arthur Allen, KFF Health News
February 16, 2024
10:59 am

A restructuring of the Medicare drug benefit has wiped out big drug price bills for people who need expensive medicines. But the legal battle over drug negotiations means uncertainty over long-term savings.

A new test could save arthritis patients time, money and pain. But will it be used?
A new test could save arthritis patients time, money and pain. But will it be used?
Arthur Allen, KFF Health News
December 20, 2023
2:05 pm

Pain, drug-hopping and insurance meddling is all too common among patients with rheumatoid arthritis.

Biden administration’s limit on drug industry middlemen backfires, pharmacists say
Biden administration’s limit on drug industry middlemen backfires, pharmacists say
Arthur Allen, KFF Health News
November 16, 2023
7:00 am

The so-called PBMs have long clawed back a fee from pharmacies weeks or months after they dispense a drug.

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice
Save billions or stick with Humira? Drug brokers steer Americans to the costly choice
Arthur Allen, KFF Health News
September 19, 2023
3:00 pm

Makers of biosimilars must still work within a health care system in which basic economics rarely seems to hold sway.

Why the CDC has recommended new COVID boosters for all
Why the CDC has recommended new COVID boosters for all
Arthur Allen, KFF Health News
September 13, 2023
10:00 am

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted 13-1 for the motion after months of debate about whether to limit its recommendation to high-risk groups.

  • From Our Partners